NCT06703632View on ClinicalTrials.gov

Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection

NARecruitingINTERVENTIONAL
Enrollment

4,538

Participants

Timeline

Start Date

January 14, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Screening for Colon CancerBlood SamplesSurvey and QuestionnaireColorectal CarcinomaColon AdenocarcinomaPrecancerous Lesion of Colon
Interventions
DIAGNOSTIC_TEST

blood sampling

PreveCol test based on blood sampling

OTHER

Survey using a questionnaire.

Preference questionnaire for colorectal cancer screening methods

OTHER

Survey using a questionnaire.

PREMs for colorectal cancer screening programme

Trial Locations (2)

Unknown

NOT_YET_RECRUITING

Hospital de Santa Maria, Lisbon

RECRUITING

Hospital Universitario Ramon y Cajal, Madrid

All Listed Sponsors
collaborator

Hospital Universitario Ramon y Cajal

OTHER

collaborator

Hospital de Santa Maria, Lisbon

UNKNOWN

lead

ADVANCED MARKER DISCOVERY S.L.

INDUSTRY